These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 9841004)

  • 1. Screening for nuchal translucency. Patients give consent by attending for ultrasound scans.
    Nash TG
    BMJ; 1998 Sep; 317(7160):749. PubMed ID: 9841004
    [No Abstract]   [Full Text] [Related]  

  • 2. Informed decision making in the context of prenatal screening.
    van den Berg M; Timmermans DR; ten Kate LP; van Vugt JM; van der Wal G
    Patient Educ Couns; 2006 Oct; 63(1-2):110-7. PubMed ID: 16242899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Education and quality review for nuchal translucency ultrasound.
    D'Alton ME; Cleary-Goldman J
    Semin Perinatol; 2005 Dec; 29(6):380-5. PubMed ID: 16533651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
    Sepulveda W; Wong AE; Dezerega V
    Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenging the rhetoric of choice in prenatal screening.
    Seavilleklein V
    Bioethics; 2009 Jan; 23(1):68-77. PubMed ID: 19076943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for nuchal translucency. Women are unaware that they can refuse an ultrasound scan.
    Hampton K
    BMJ; 1998 Sep; 317(7160):748-9. PubMed ID: 9841001
    [No Abstract]   [Full Text] [Related]  

  • 7. Does offering and performing prenatal screening influence women's attachment to their unborn child? A longitudinal randomized controlled trial.
    Kleinveld JH; Timmermans DR; van den Berg M; van Eijk JT; Ten Kate LP
    Prenat Diagn; 2007 Aug; 27(8):757-64. PubMed ID: 17546705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
    Papageorghiou AT; Avgidou K; Spencer K; Nix B; Nicolaides KH
    Am J Obstet Gynecol; 2006 Feb; 194(2):397-401. PubMed ID: 16458636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women as moral pioneers? Experiences of first trimester antenatal screening.
    Williams C; Sandall J; Lewando-Hundt G; Heyman B; Spencer K; Grellier R
    Soc Sci Med; 2005 Nov; 61(9):1983-92. PubMed ID: 15899542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal chromosomal abnormalities: antenatal screening and diagnosis.
    Anderson CL; Brown CE
    Am Fam Physician; 2009 Jan; 79(2):117-23. PubMed ID: 19178062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-trimester and second-trimester screening at a community hospital: experience from the first year of implementation.
    Philipson EH; Callahan M; Jelovsek JE
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):218-22. PubMed ID: 18669714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The commodification of obstetric ultrasound scanning in Hanoi, Viet Nam.
    Gammeltoft T; Nguyen HT
    Reprod Health Matters; 2007 May; 15(29):163-71. PubMed ID: 17512387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pregnant women's assessment and level of knowledge of prenatal counseling].
    Tschudin S; Holzgreve W; Conde N; Alder J; Bitzer J; Tercanli S
    Ultraschall Med; 2009 Apr; 30(2):157-62. PubMed ID: 18484059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A qualitative study of pregnant women's choice of nuchal translucency measurement].
    Lou S; Dahl K; Risør MB; Hvidman LE; Thomsen SG; Jørgensen FS; Olesen F; Kjaergaard H; Kesmodel U
    Ugeskr Laeger; 2007 Mar; 169(10):914-8. PubMed ID: 17359736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of prenatal ultrasound for the detection of fetal aneuploidy.
    Holmgren C; Lacoursiere DY
    Clin Obstet Gynecol; 2008 Mar; 51(1):48-61. PubMed ID: 18303499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antenatal screening. Better understanding of factors influencing uptake is needed.
    Dormandy E
    BMJ; 1999 Mar; 318(7186):805. PubMed ID: 10215386
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality control of an image-scoring method for nuchal translucency ultrasonography.
    Fries N; Althuser M; Fontanges M; Talmant C; Jouk PS; Tindel M; Duyme M
    Am J Obstet Gynecol; 2007 Mar; 196(3):272.e1-5. PubMed ID: 17346552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality of nuchal transluccency measurements: an exploratory study into their performance and evaluation].
    van den Berg M; Kleinveld JH; Sander MJ; van Vugt JM; Timmermans DR
    Ned Tijdschr Geneeskd; 2005 Jul; 149(30):1691-6. PubMed ID: 16104116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum screening for anomalies in pregnancy: reasons for acceptance or refusal of the test.
    Gokhale LS; Cietak KA
    J Obstet Gynaecol; 2002 Jul; 22(4):392-3. PubMed ID: 12521462
    [No Abstract]   [Full Text] [Related]  

  • 20. Informed consent in medical research. Patients may not understand enough to give their informed consent.
    Montgomery C; Lydon A; Lloyd K
    BMJ; 1997 May; 314(7092):1482. PubMed ID: 9167585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.